We are live on ! Find out more
INAB icon

IN8bio
INAB

29 hedge funds and large institutions have $11.4M invested in IN8bio in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

342% more capital invested

Capital invested by funds: $2.58M → $11.4M (+$8.82M)

38% more funds holding

Funds holding: 21 → 29 (+8)

0.63% more ownership

Funds ownership: 0.26% → 0.89% (+0.63%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

Holders
29
Holders Change
+8
Holders Change %
+38.1%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
6
Closed
–
Calls
$1.13M
Puts
–
Net Calls
+$1.13M
Net Calls Change
+$1.13M

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$4.37M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$873K
3
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$691K
4
6CM
683 Capital Management
New York
+$655K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$83.1K

Top Sellers

Rank Fund Capital Flow
1
VC
Voss Capital
Texas
-$182K
2
SPC
Sigma Planning Corp
Michigan
-$163K
3
Wells Fargo
Wells Fargo
California
-$10.7K
4
TRCT
Tower Research Capital (TRC)
New York
-$6.01K
5
BlackRock
BlackRock
New York
-$927
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$5.22M +$4.37M +136,612 New
Ensign Peak Advisors
2
Ensign Peak Advisors
Utah
$1.54M +$691K +21,608 +138%
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$1.12M +$873K +27,322 New
6CM
4
683 Capital Management
New York
$848K +$655K +20,492 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$575K +$83.1K +2,599 +23%
VC
6
Voss Capital
Texas
$471K -$182K -5,679 -33%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$275K +$11.3K +352 +6%
SIG
8
Stonegate Investment Group
Alabama
$248K – – –
RCG
9
Rock Creek Group
District of Columbia
$209K – – –
SPC
10
Sigma Planning Corp
Michigan
$182K -$163K -5,094 -54%
TCBWMS
11
Texas Capital Bank Wealth Management Services
Texas
$109K +$38.6K +1,206 +85%
BCM
12
Bridgeway Capital Management
Texas
$108K – – –
State Street
13
State Street
Massachusetts
$81.8K – – –
Northern Trust
14
Northern Trust
Illinois
$67.6K +$6.14K +192 +13%
Two Sigma Investments
15
Two Sigma Investments
New York
$58.4K +$45.1K +1,411 New
LNWTC
16
Laird Norton Wetherby Trust Company
Washington
$58.4K +$45.1K +1,410 New
OMC
17
Overbrook Management Corp
New York
$46.6K – – –
BlackRock
18
BlackRock
New York
$39.8K -$927 -29 -3%
Citadel Advisors
19
Citadel Advisors
Florida
$27.3K +$21.1K +660 New
Renaissance Technologies
20
Renaissance Technologies
New York
$27K +$20.9K +653 New
WIM
21
Westside Investment Management
California
$20K – – –
Charles Schwab
22
Charles Schwab
California
$18.1K – – –
HighTower Advisors
23
HighTower Advisors
Illinois
$14K – – –
Vontobel Holding
24
Vontobel Holding
Switzerland
$13.9K +$10.6K +333 New
TRCT
25
Tower Research Capital (TRC)
New York
$8.4K -$6.01K -188 -48%
1
2

INAB Hedge Fund Activity: Q4 2023 in Review

29 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q4 2023, worth a combined $11.4M — up 342% from $2.58M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new INAB positions and 0 closed out — a net gain of 8 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $4.37M. The largest seller was Voss Capital, cutting an estimated $182K.

  • 29 institutional investors held IN8bio (INAB) as of Q4 2023, up from 21 in Q3 2023.
  • Funds reported $11.4M of IN8bio stock for Q4 2023, up 342% quarter-over-quarter.
  • 8 funds opened new IN8bio positions in Q4 2023 and 0 closed out, a net change of +8 holders.
  • The largest IN8bio buyer in Q4 2023 was AIGH Capital Management, an estimated $4.37M added.
  • The largest IN8bio seller in Q4 2023 was Voss Capital, an estimated $182K sold.

Based on aggregated 13F filings for Q4 2023.